Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme
Clinical trial NCT00086879 · COMPLETED
Trial details
- NCT number
- NCT00086879
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2006-03-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.